Published in Genes Dev on December 01, 2013
CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature (2014) 3.28
CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. Mol Cell (2014) 2.87
High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet (2015) 2.35
Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system. Sci Rep (2014) 1.83
Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage. PLoS One (2014) 1.38
Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer (2015) 1.32
Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9. J Mol Cell Biol (2015) 1.07
In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol (2017) 1.04
Adenovirus-mediated efficient gene transfer into cultured three-dimensional organoids. PLoS One (2014) 1.03
CRISPR/Cas9-induced knockout and knock-in mutations in Chlamydomonas reinhardtii. Sci Rep (2016) 0.94
A versatile modular vector system for rapid combinatorial mammalian genetics. J Clin Invest (2015) 0.89
Precision cancer mouse models through genome editing with CRISPR-Cas9. Genome Med (2015) 0.89
Modeling Disease In Vivo With CRISPR/Cas9. Trends Mol Med (2015) 0.87
Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing. Genome Med (2015) 0.87
eIF4AII is dispensable for miRNA-mediated gene silencing. RNA (2015) 0.86
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system. J Orthop Res (2014) 0.86
A versatile reporter system for CRISPR-mediated chromosomal rearrangements. Genome Biol (2015) 0.86
Bacterial cellular engineering by genome editing and gene silencing. Int J Mol Sci (2014) 0.83
A new age in functional genomics using CRISPR/Cas9 in arrayed library screening. Front Genet (2015) 0.83
The retroviral vector family: something for everyone. Virus Genes (2017) 0.83
PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing. Nat Commun (2015) 0.82
Using CRISPR/Cas to study gene function and model disease in vivo. FEBS J (2016) 0.82
Application of TALEs, CRISPR/Cas and sRNAs as trans-acting regulators in prokaryotes. Curr Opin Biotechnol (2014) 0.81
Structure Principles of CRISPR-Cas Surveillance and Effector Complexes. Annu Rev Biophys (2015) 0.80
Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogen. Cancer Lett (2014) 0.79
Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system. Mol Ther Methods Clin Dev (2014) 0.79
Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter. J Biotechnol (2014) 0.78
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma. Cancer Lett (2016) 0.78
CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases. Oncotarget (2016) 0.75
Restriction of Nonpermissive RUNX3 Protein Expression in T Lymphocytes by the Kozak Sequence. J Immunol (2015) 0.75
Visualization analysis of CRISPR/Cas9 gene editing technology studies. J Zhejiang Univ Sci B (2016) 0.75
A stable but reversible integrated surrogate reporter for assaying CRISPR/Cas9-stimulated homology-directed repair. J Biol Chem (2017) 0.75
Kaiso mediates human ICR1 methylation maintenance and H19 transcriptional fine regulation. Clin Epigenetics (2016) 0.75
A CRISPR/Cas9 Functional Screen Identifies Rare Tumor Suppressors. Sci Rep (2016) 0.75
CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling. Int J Mol Sci (2015) 0.75
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00
Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol (2013) 21.32
DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol (2013) 19.99
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01
RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol (2013) 15.51
RNA-programmed genome editing in human cells. Elife (2013) 14.82
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 14.28
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell (2013) 13.43
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat (2007) 12.98
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol (2013) 11.58
Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell (2008) 11.24
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res (2011) 10.43
Tumor growth need not be driven by rare cancer stem cells. Science (2007) 10.34
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet (2005) 8.99
Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics (2013) 8.56
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol (2013) 8.40
One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell (2013) 7.99
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res (2013) 7.77
Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res (2013) 7.41
Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc Natl Acad Sci U S A (2011) 6.89
Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res (2013) 6.89
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev (1999) 6.87
Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods (2013) 5.93
p53 mutations in cancer. Nat Cell Biol (2013) 5.18
Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep (2013) 4.72
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci U S A (2006) 4.68
Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc Natl Acad Sci U S A (2013) 4.57
Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol (2013) 4.19
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res (2013) 4.11
Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell (2013) 4.05
Tracking genome engineering outcome at individual DNA breakpoints. Nat Methods (2011) 4.05
Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat Biotechnol (2013) 3.84
Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol (2013) 3.65
Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol (2010) 3.65
Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat Methods (2013) 3.59
CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu Rev Biochem (2013) 3.55
Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 3.20
Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis, tobacco, sorghum and rice. Nucleic Acids Res (2013) 2.99
Lessons from Nature: microRNA-based shRNA libraries. Nat Methods (2006) 2.80
Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS One (2013) 2.74
Efficient genome editing in plants using a CRISPR/Cas system. Cell Res (2013) 2.57
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol (2013) 2.44
A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. Mol Ther (2008) 2.31
Targeted mutagenesis in rice using CRISPR-Cas system. Cell Res (2013) 2.00
Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin. Cancer Res (2007) 1.97
Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans. Genetics (2013) 1.69
Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors. Proc Natl Acad Sci U S A (2012) 1.17
Life in the fast lane: mammalian disease models in the genomics era. Cell (2012) 1.08
Differential detergent fractionation of eukaryotic cells. Cold Spring Harb Protoc (2011) 0.88
miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev (2002) 19.24
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature (2004) 8.76
Short RNAs repress translation after initiation in mammalian cells. Mol Cell (2006) 6.70
Statistical practice in high-throughput screening data analysis. Nat Biotechnol (2006) 5.85
Antimicrobial drug discovery through bacteriophage genomics. Nat Biotechnol (2004) 4.17
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat Chem Biol (2006) 3.89
The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci U S A (2005) 3.84
Dissecting eIF4E action in tumorigenesis. Genes Dev (2007) 3.53
eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell (2007) 3.46
Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Mol Biol Cell (2006) 2.84
mTORC1 promotes survival through translational control of Mcl-1. Proc Natl Acad Sci U S A (2008) 2.50
Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J (2006) 2.41
Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest (2008) 2.40
Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci U S A (2009) 2.40
Comparative genomic analysis of 18 Pseudomonas aeruginosa bacteriophages. J Bacteriol (2006) 2.18
Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. PLoS One (2009) 2.11
Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc Natl Acad Sci U S A (2005) 2.00
Mapping chromatin interactions by chromosome conformation capture. Curr Protoc Mol Biol (2006) 1.95
Structural conservation of druggable hot spots in protein-protein interfaces. Proc Natl Acad Sci U S A (2011) 1.95
A tumour suppressor network relying on the polyamine-hypusine axis. Nature (2012) 1.85
Three-dimensional modeling of chromatin structure from interaction frequency data using Markov chain Monte Carlo sampling. BMC Bioinformatics (2011) 1.78
Complexity of chromatin folding is captured by the strings and binders switch model. Proc Natl Acad Sci U S A (2012) 1.73
RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation. Chem Biol (2006) 1.71
Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs. RNA (2008) 1.69
Altering chemosensitivity by modulating translation elongation. PLoS One (2009) 1.68
Chromatin conformation signatures of cellular differentiation. Genome Biol (2009) 1.68
Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci U S A (2005) 1.65
The Gemin6-Gemin7 heterodimer from the survival of motor neurons complex has an Sm protein-like structure. Structure (2005) 1.64
Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res (2004) 1.62
High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay. J Biomol Screen (2005) 1.61
Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Genes Dev (2008) 1.60
Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res (2006) 1.60
Caliciviruses differ in their functional requirements for eIF4F components. J Biol Chem (2006) 1.60
Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2.GTP.Met-tRNA(i)(Met) ternary complex availability. Mol Biol Cell (2006) 1.51
Uncoupling stress granule assembly and translation initiation inhibition. Mol Biol Cell (2009) 1.49
Selective pharmacological targeting of a DEAD box RNA helicase. PLoS One (2008) 1.49
Problems with co-funding in Canada. Science (2005) 1.48
T cell protein tyrosine phosphatase deficiency results in spontaneous synovitis and subchondral bone resorption in mice. Arthritis Rheum (2012) 1.46
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma. J Exp Med (2011) 1.45
Gemins modulate the expression and activity of the SMN complex. Hum Mol Genet (2005) 1.42
Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Angew Chem Int Ed Engl (2007) 1.40
c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res (2008) 1.40
Improving the practice of child death overview panels: a paediatric perspective. Arch Dis Child (2013) 1.39
The three-dimensional architecture of Hox cluster silencing. Nucleic Acids Res (2010) 1.36
Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases. Cancer Res (2011) 1.35
A novel function of eIF2alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathway. Mol Biol Cell (2007) 1.32
Disease-causing 7.4 kb cis-regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening. PLoS Genet (2009) 1.32
Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site. J Biol Chem (2011) 1.31
Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. Proc Natl Acad Sci U S A (2010) 1.30
Appropriateness of imaging in Canada. Can Assoc Radiol J (2013) 1.28
Inhibition of translation by RNA-small molecule interactions. RNA (2002) 1.27
Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis (2008) 1.26
A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus. Bioorg Med Chem (2006) 1.23
Translation of nonSTOP mRNA is repressed post-initiation in mammalian cells. EMBO J (2007) 1.20
Seminiferous tubule degeneration and infertility in mice with sustained activation of WNT/CTNNB1 signaling in sertoli cells. Biol Reprod (2008) 1.17
Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. RNA (2004) 1.15
A cellular response linking eIF4AI activity to eIF4AII transcription. RNA (2012) 1.13
Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex. ACS Chem Biol (2013) 1.12
Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis. Cell Rep (2012) 1.12
Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. FASEB J (2010) 1.10
In support of the BMRB. Nat Struct Mol Biol (2012) 1.09
Targeting translation dependence in cancer. Oncotarget (2011) 1.09
Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells. Leuk Res (2009) 1.09
c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy. Cancer Res (2009) 1.08
The herpes simplex virus 1 vhs protein enhances translation of viral true late mRNAs and virus production in a cell type-dependent manner. J Virol (2011) 1.08
Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor. Nat Genet (2005) 1.05
The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice. Nat Commun (2012) 1.05
Biomimetic photocycloaddition of 3-hydroxyflavones: synthesis and evaluation of rocaglate derivatives as inhibitors of eukaryotic translation. Angew Chem Int Ed Engl (2010) 1.05
Dysregulation of WNT/CTNNB1 and PI3K/AKT signaling in testicular stromal cells causes granulosa cell tumor of the testis. Carcinogenesis (2009) 1.04
Emerging therapeutics targeting mRNA translation. Cold Spring Harb Perspect Biol (2012) 1.04
Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing. Nucleic Acids Res (2010) 1.03
2'-fluoro-4'-thioarabino-modified oligonucleotides: conformational switches linked to siRNA activity. Nucleic Acids Res (2007) 1.03
An upstream open reading frame impedes translation of the huntingtin gene. Nucleic Acids Res (2002) 1.03
Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies. J Med Chem (2011) 1.03
Inhibitors of translation initiation as cancer therapeutics. Future Med Chem (2009) 1.02
Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. Cancer Res (2002) 1.02
Internal translation initiation mediated by the angiogenic factor Tie2. J Biol Chem (2005) 1.01
WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2. Oncogene (2003) 1.01
Hepatitis C virus-related internal ribosome entry sites are found in multiple genera of the family Picornaviridae. J Gen Virol (2006) 0.99
A modular and flexible ESC-based mouse model of pancreatic cancer. Genes Dev (2014) 0.99
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a novel RNA-binding protein that inhibits protein synthesis. J Neurosci Res (2009) 0.99
Heat-induced dimerization of BCL-xL through alpha-helix swapping. Biochemistry (2007) 0.97
Cap-dependent eukaryotic initiation factor-mRNA interactions probed by cross-linking. RNA (2008) 0.96